Yosemite-backed Quarry receives FDA fast-track designation by mid-2027
Resolves: FDA grants Quarry Fast Track designation for its lead oncology candidate based on robust preclinical and early clinical data.
user-generated· regulatory
Yosemite-backed Quarry receives FDA fast-track designation by mid-2027
Market overview
Quarry, co-founded with serial entrepreneur Craig Crews, is developing an induced proximity therapeutic platform for cancer. The novel mechanism and strong preclinical data make it a prime candidate for FDA fast-track designation, accelerating its path to approval.
regulatory prediction market
- Implied probability (Yes)
- 70%
- Closes
- 2027-06-30
About this prediction
Resolution criteria
FDA grants Quarry Fast Track designation for its lead oncology candidate based on robust preclinical and early clinical data.
Source: user-generated
More regulatory markets
- Crypto billionaire Harborne faces FCA scrutiny over £5m gift — 55% Yes
- Crypto billionaire Harborne will face FCA scrutiny — 60% Yes
- Crypto billionaire Christopher Harborne’s donation triggers FCA inquiry into funding transparency — 70% Yes
- Crypto billionaire Christopher Harborne will face parliamentary scrutiny over £5m gift — 55% Yes
- Harborne crypto holdings face regulatory scrutiny — 60% Yes
- SEC approves at least 2 new Bitcoin ETFs by Q4 2027 — 75% Yes
- SEC approves Kalshi's crypto futures products by 2026-Q3 — 55% Yes
- Iran's central bank bans crypto mining by 2027 Q1 — 85% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…